Pediatric lung transplantation: Indications and outcomes

Journal of Thoracic Disease

Volumn 6, Issue 8, 2014, Pages 1024-1031

  Kirkby, Stephen ^a   Hayes, Don ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Indications; Infants; Lung transplantation (LTx); Pediatrics; Survival

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; LUNG SURFACTANT;

ADOLESCENT; BRONCHIOLITIS OBLITERANS; CHILD; COMORBIDITY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; FATALITY; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; INCIDENCE; INFANT; INTERSTITIAL LUNG DISEASE; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG TRANSPLANTATION; OVERALL SURVIVAL; PEDIATRICS; PULMONARY HYPERTENSION; RETRANSPLANTATION; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84907011106     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.04.27     Document Type: Review

References (50)

1. Hardy JD, Webb WR, Dalton ML, et al. Lung Homotransplantation in Man. JAMA 1963;186:1065-74.
2. Sweet SC. Pediatric lung transplantation. Proc Am Thorac Soc 2009;6:122-7.
3. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011;184:159-71.
4. Mendeloff EN. The history of pediatric heart and lung transplantation. Pediatr transplant 2002;6:270-9.
5. Huddleston CB, Bloch JB, Sweet SC, et al. Lung transplantation in children. Ann surg 2002;236:270-6.
6. Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report--2013; focus theme: age. J Heart Lung Transplant 2013;32:965-78.
7. Benden C, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric lung and heartlung transplantation report--2013; focus theme: age. J Heart Lung Transplant 2013;32:989-97.
8. Zafar F, Heinle JS, Schecter MG, et al. Two decades of pediatric lung transplant in the United States: have we improved? J Thorac Cardiovasc Surg 2011;141:828-32, 832.e1.
9. Huddleston CB. Surgical complications of lung transplantation in children. Semin Thorac Cardiovasc Surg 1996;8:296-304.
10. Huddleston CB. Pediatric lung transplantation. Curr Treat Options Cardiovasc Med 2011;13:68-78.
11. Ibrahim JE, Sweet SC, Flippin M, et al. Rejection is reduced in thoracic organ recipients when transplanted in the first year of life. J Heart Lung Transplant 2002;21:311-8.
12. Liu M, Worley S, Arrigain S, et al. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis 2009;11:304-12.
13. Liu M, Mallory GB, Schecter MG, et al. Long-term impact of respiratory viral infection after pediatric lung transplantation. Pediatr Transplant 2010;14:431-6.
14. Benden C, Aurora P, Curry J, et al. High prevalence of gastroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 2005;40:68-71.
15. Devine KA, Reed-Knight B, Loiselle KA, et al. Predictors of long-term health-related quality of life in adolescent solid organ transplant recipients. J Pediatr Psychol 2011;36:891-901.
16. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006;173:475-82.
17. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005;352:1992-2001.
18. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
19. Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365:1663-72.
20. Cystic Fibrosis Foundation Patient Registry, 2012 Annual Data Report Bethesda, Maryland©2013 Cystic Fibrosis Foundation. Available online: http://www.cff.org/ livingwithcf/qualityimprovement/patientregistryreport/
21. Ivy DD, Abman SH, Barst RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol 2013;62:D117-26.
22. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
23. Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006. Heart 2009;95:312-7.
24. Barst RJ, McGoon MD, Elliott CG, et al. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation 2012;125:113-22.
25. Barst RJ, Ertel SI, Beghetti M, et al. Pulmonary arterial hypertension: a comparison between children and adults. Eur Respir J 2011;37:665-77.
26. Goldstein BS, Sweet SC, Mao J, et al. Lung transplantation in children with idiopathic pulmonary arterial hypertension: an 18-year experience. J Heart Lung Transplant 2011;30:1148-52.
27. Hamvas A, Deterding R, Balch WE, et al. Diffuse lung disease in children: Summary of a scientific conference. Pediatr Pulmonol 2014;49:400-9.
28. Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013;188:376-94.
29. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009;12:253-74.
30. Whitsett JA. Genetic disorders of surfactant homeostasis. Paediatr Respir Rev 2006;7 Suppl 1:S240-2.
31. Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350:1296-303.
32. Nogee LM, Garnier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994;93:1860-3.
33. Nogee LM, Dunbar AE 3rd, Wert S, et al. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 2002;121:20S-21S.
34. Palomar LM, Nogee LM, Sweet SC, et al. Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. J Pediatr 2006;149:548-53.
35. Bishop NB, Stankiewicz P, Steinhorn RH. Alveolar capillary dysplasia. Am J Respir Crit Care Med 2011;184:172-9.
36. Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol 2002;33:466-74.
37. Fischer GB, Sarria EE, Mattiello R, et al. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev 2010;11:233-9.
38. Nishio N, Yagasaki H, Takahashi Y, et al. Late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children. Bone Marrow Transplant 2009;44:303-8.
39. Uhlving HH, Buchvald F, Heilmann CJ, et al. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transplant 2012;47:1020-9.
40. Snell GI, Paraskeva M, Westall GP. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold? Paediatr Drugs 2013;15:281-9.
41. Scully BB, Zafar F, Schecter MG, et al. Lung retransplantation in children: appropriate when selectively applied. Ann Thorac Surg 2011;91:574-9.
42. Valapour M, Paulson K, Smith JM, et al. OPTN/SRTR 2011 Annual Data Report: Lung. Am J Transplant 2013;13:149-77.
43. Liou TG, Adler FR, Cox DR, et al. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007;357:2143-52.
44. Thabut G, Christie JD, Mal H, et al. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. Am J Respir Crit Care Med 2013;187:1335-40.
45. Sweet SC, Aurora P, Benden C, et al. Lung transplantation and survival in children with cystic fibrosis: solid statistics-- flawed interpretation. Pediatr Transplant 2008;12:129-36.
46. Adler FR, Aurora P, Barker DH, et al. Lung transplantation for cystic fibrosis. Proc Am Thorac Soc 2009;6:619-33.
47. Aris RM, Routh JC, LiPuma JJ, et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001;164:2102-6.
48. De Soyza A, McDowell A, Archer L, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001;358:1780-1.
49. Rama JA, Fan LL, Faro A, et al. Lung transplantation for childhood diffuse lung disease. Pediatr Pulmonol 2013;48:490-6.
50. Khan MS, Heinle JS, Samayoa AX, et al. Is lung transplantation survival better in infants? Analysis of over 80 infants. J Heart Lung Transplant 2013;32:44-9.